What are you looking for?
Florence, Italy – Landing Med highlighted its groundbreaking technologies at the 2024 European Congress of Pathology (ECP) in Florence, Italy, from September 7-11, showcasing advancements in digital cytology and AI-driven cancer diagnostics.
A key exhibit was the CE-marked LD Patho 320A, a compact, affordable digital slide scanner designed for small labs, research institutes, and educational settings. With its portability and cloud integration, the LD Patho 320A offers a cost-effective solution for efficient diagnostics, making advanced pathology tools accessible to more healthcare institutions.
In addition, Dr. Pang, Landing Med’s CTO, presented the company’s latest research on AI-powered thyroid cancer diagnosis. The AI algorithms, integrated with digital pathology, enhance diagnostic accuracy, speed up the process, and assist cytopathologists in identifying early-stage cancers. This technology provides improved decision support, faster diagnoses, and greater scalability for healthcare providers, from large hospitals to smaller labs.
Landing Med’s participation at ECP 2024 reinforces its commitment to improving healthcare accessibility, particularly in low-resource regions. By making advanced diagnostic tools more affordable and widely available, the company is empowering pathology professionals worldwide to deliver more efficient diagnoses, advancing global cancer detection.
